# Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia

> **NIH NIH N01** · DUKE UNIVERSITY · 2020 · $668,565

## Abstract

The Vaccine and Treatment Evaluation Units (VTEUs) are a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising vaccines and treatments for infectious disease. Investigations of novel product delivery systems and routes of delivery may also be conducted. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

## Key facts

- **NIH application ID:** 10204827
- **Project number:** 272201300017I-P00007-27200008-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** SUSANNA NAGGIE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $668,565
- **Award type:** —
- **Project period:** 2015-06-10 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10204827

## Citation

> US National Institutes of Health, RePORTER application 10204827, Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia (272201300017I-P00007-27200008-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10204827. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*